North America Optogenetics Market

North America Optogenetics Market Size (2023 to 2028)

The optogenetics Market size in North America was worth USD 15.54 billion in 2023 and is estimated to reach USD 31.81 billion by 2028, registering a CAGR of 15.4% from 2023 to 2028.

The rise in the incidences of neurological and psychiatric disorders is majorly driving the North American optogenetics market. Optogenetics is a special treatment procedure in neuroscience with all new methods that help cure various diseases such as depression, addiction, and others. The attribute mentioned above is undoubtedly promoting the growth rate of the market in North America. Also, collaborations with pharmaceutical companies are expanding the demand for the optogenetics market in this region. Furthermore, increasing disposable income in urban areas is also promoting the growth rate of the market. Also, the growing prevalence of effective treatment procedures is leveling up the demand of the market.

Furthermore, growing awareness over the treatment procedures among individuals, governments' initiatives to improve the quality of services in healthcare centers, the emergence of the latest technologies, and the launch of innovative devices in neuroscience are further propelling the growth rate of the North American optogenetics market. Also, private and public organizations' increasing investments in hospitals and clinics and ongoing research on the development of new techniques in favor of the end-users are expected to act favorably to the market’s growth rate. 

However, equipment in laboratories needs massive amounts for installation and maintenance, which is slowly declining the market's growth rate. In addition, the dearth of skilled physicians or doctors due to fewer training programs in some rural areas hinders the demand of the optogenetics market in North America. The main challenging attribute for the market developers is the lack of complete knowledge over the usage of new devices in diagnostic centers. Lack of standardization is another factor inhibiting the growth rate of the North American optogenetics market. 

This research report on the North American optogenetics market has been segmented & sub-segmented into the following categories:

By Sensor Type: 

• Genetically Encoded Calcium Indicators
• pH Sensors
• Neurotransmitter Release
• Voltage-Sensitive Fluorescent Proteins

By Techniques: 

• Archaerhodopsin
• Channelrhodopsin
• Halorhodopsin

By Application: 

• Retinal Disease Treatment
• Cardioversion
• Neuroscience
• Behavioral Tracking and Pacing

By Light Equipment: 

• Lasers
• LEDs
• Others

By Country:  

• The United States
• Canada
• Rest of North America

Regionally, North America and predominantly the United States is the largest market for optogenetics in the world. In addition, neuroscience and optogenetic research activities are being conducted on a large scale in the North American region. Therefore, Optogenetics in North America is expected to follow the general biotechnology market trends in the region.

KEY MARKET PLAYERS:

A few notable companies operating in the North American optogenetics market are Coherent Inc., Noldus, Thorlabs Inc., Cobalt Inc., Scientifica, Bruker, Laserglow technologies, Regenxbio Inc., Gensight, Addgene, UPenn Vector Core, and Jackson Laboratories.